跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,627 条关于
“Rezolute Bio”
全部
5,627
临床试验
2,486
药物
1,024
机构
270
资讯
1,847
10个月前
XOMA Royalty Reports Strong Q3 2025 Results with Multiple Strategic Acquisitions and Key Pipeline Milestones
去年
FDA Budget Cuts Under Trump Administration Threaten Drug Development Pipeline
去年
Sidra Medicine Conducts First Clinical Trial for Pediatric Congenital Hyperinsulinism
去年
Congenital Hyperinsulinism Pipeline Shows Promise with Multiple Therapies Advancing Through Clinical Development
去年
Big Pharma M&A Activity Surges as Companies Target Undervalued Biotechs Amid Market Recovery
去年
Rezolute Secures $90 Million in Public Offering to Advance Rare Disease Therapies
去年
Rezolute's Ersodetug Advances in Phase 3 Trials for Hyperinsulinism
去年
FDA Lifts Clinical Holds on Rezolute's Ersodetug (RZ358) for Congenital Hyperinsulinism
去年
Rezolute's Ersodetug Advances in Phase 3 for Hyperinsulinism; RZ402 Shows Promise in DME
去年
Ersodetug Receives FDA Breakthrough Therapy Designation for Congenital Hyperinsulinism
第 1 页,共 185 页
上一页
下一页